Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study
- I. Stratton, A. Adler, R. Holman
- MedicineBMJ : British Medical Journal
- 12 August 2000
In patients with type 2 diabetes the risk of diabetic complications was strongly associated with previous hyperglycaemia, with the lowest risk being in those with HbA1c values in the normal range (<6.0%).
Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study
- A. Adler, I. Stratton, R. Holman
- MedicineBMJ : British Medical Journal
- 12 August 2000
In patients with type 2 diabetes the risk of diabetic complications was strongly associated with raised blood pressure, with the lowest risk being in those with systolic blood pressure less than 120 mm Hg.
The UKPDS risk engine: a model for the risk of coronary heart disease in Type II diabetes (UKPDS 56).
- R. Stevens, V. Kothari, A. Adler, I. Stratton
- MedicineClinical science
- 1 December 2001
The model is diabetes-specific and incorporates glycaemia, systolic blood pressure and lipid levels as risk factors, in addition to age, sex, ethnic group, smoking status and time since diagnosis of diabetes, which provides the estimates ofCHD risk required by current guidelines for the primary prevention of CHD in Type II diabetes.
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)
- R. Turner, R. Holman, Grp Ukpds.
- MedicineThe Lancet
- 11 September 1998
UKPDS 50: Risk factors for incidence and progression of retinopathy in Type II diabetes over 6 years from diagnosis
- I. Stratton, E. Kohner, for theUKPDS Group
- MedicineDiabetologia
- 1 February 2001
Development of retinopathy (incidence) was strongly associated with baseline glycaemia, glycaemic exposure over 6 years, higher blood pressure and with not smoking and progression was associated with older age, male sex, hyperglycaemia (as evidenced by a higher HbA1 c) and withNot smoking.
UKPDS 25: autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes
- R. Turner, I. Stratton, R. Holman
- MedicineThe Lancet
- 1 November 1997
Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom prospective diabetes study (UKPDS: 23)
A quintet of potentially modifiable risk factors for coronary artery disease exists in patients with type 2 diabetes mellitus, which are increased concentrations of low density lipoprotein cholesterol, decreased concentrations of high density cholesterol, raised blood pressure, hyperglycaemia, and smoking.
International Subarachnoid Aneurysm Trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomized trial.
- A. Molyneux, R. Kerr, R. Holman
- MedicineJournal of Stroke & Cerebrovascular Diseases
- 1 November 2002
In patients with a ruptured intracranial aneurysm, for which endovascular coiling and neurosurgical clipping are therapeutic options, the outcome in terms of survival free of disability at 1 year is significantly better with endov vascular coiling.
A model to estimate the lifetime health outcomes of patients with Type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model (UKPDS no. 68)
- P. Clarke, A. Gray, O. B. O. T. I. Group
- MedicineDiabetologia
- 27 October 2004
The USPDS Outcomes Model is able to simulate event histories that closely match observed outcomes in the UKPDS and that can be extrapolated over patients’ lifetimes, which should assist in informing future economic evaluations of interventions in Type 2 diabetes.
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes…
- R. Turner, C. Fox, Michael Gnant
- Medicine
- 11 September 1998
The effects of intensive blood-glucose control with either sulphonylurea or insulin and conventional treatment on the risk of microvascular and macrovascular complications in patients with type 2 diabetes in a randomised controlled trial were compared.
...
...